ISPOR - EE38 A Review of Cost Effectiveness Analysis (CEA) of Immuno-Oncologic Therapies for Squamous Cell Carcinoma Head and Neck Cancer (SCCHN): Lessons Learned

EE38 A Review of Cost Effectiveness Analysis (CEA) of Immuno-Oncologic Therapies for Squamous Cell Carcinoma Head and Neck Cancer (SCCHN): Lessons Learned

Abstract

Authors

J Chheda AJ Ambegaonkar

Full Text Cite This Article

Back to Volume 25, Supplemental Issue 7S

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now